Diabetes Clinical Trials
Need course dates or locations to suit you? CLICK HERE TO SEND ENQUIRY...  
Understand current thinking in the area of diabetes, treatment options and the relevance to clinical trial design and conduct.

What Is The Course About?
This 1-day course provides participants with an excellent overview of diabetes and alongside the comprehensive medical explanations of the disease and its treatment options, information is also provided on the demographics and economics of diabetes. This link helps organisations to understand their challenges and the importance for their research pipelines, making this a very valuable course for all clinical trials professionals.

By the end of this course, you will be able to:
- understand the importance and impact of diabetes as a disease area
- know the metabolic conditions underlying diabetes
- learn about the progress of anti-diabetic therapy
- understand current treatment paradigms
- strategically assess the future and your organisation’s competitive position

The full fee for this course is £590 +vat and includes full course materials, lunch and refreshments.

Course Programme:
 Introduction
- Demographics of Diabetes
- Economics of Diabetes
Understanding the metabolic conditions underlying Diabetes
- Pre-diabetes Syndrome
- Metabolic Syndrome
- Diabetes and Inflammation
- Diagnosis, classification, epidemiology, etc
- Progression and treatment of Diabetes (mainly Type II)
- Complications and Co-morbidities
- Treatment overview for some complications
- Dyslipidemia
- Hypertension
- Hypoglycaemia and treatment
- Diabetic foot ulcers/infections
- Neuropathic pain
- Nephropathy
- Retinopathy
- Risk factors and risk reduction strategies
Development of anti-diabetic therapy
Current treatment paradigms
- Worldwide Pharmaceutical Industry
- Diabetic Drug Market size and growth
- Epidemiology / cost of treatment
- Diabetic medications overview
- Standard therapies and combination regimens
- Drivers and trends
- Market share/forecasts overview
- Newer treatments - PPAR agonists, Alpha glucosidase inhibitors
- Insulin markets: delivery technologies, routes of administration, etc
- Other anti-diabetic therapy drug candidates
- Lipid abnormalities
- Drugs used off label - GLP-1, Niacin, etc
- Investigational new agents
- New medicines in development
- Emerging oral anti - diabetics
- Artificial Pancreas (pancreatic transplants)
- New Diagnostic Guidelines
- Diabetes tests/monitoring devices
Market trends, Challenges and strategic options
Company profiles/diabetes research pipelines
Recommended reading list
 
Need course dates or locations to suit you? CLICK HERE TO SEND ENQUIRY...  
My Location
Results for location are highlighted in the table below. Click here to remove highlight
The course either has new dates in data loading, or is only run as a dedicated or In Company course.
Tools
 
Key Details
Duration1 day
 
£590
per delegate
 
 
Bookings Helpline: 01933 233884 (Monday to Thursday - 8:00am to 5:30pm and Friday 8:00am to 5:00pm).